St. Louis, MO, United States of America

Vijai Kumar Reddy Tangadanchu

This inventor holds 1 USPTO granted patent. Top assignee: Washington University. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Vijai Kumar Reddy Tangadanchu. Retrieved from https://idiyas.com/inventor/vijai-kumar-reddy-tangadanchu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Vijai Kumar Reddy Tangadanchu

Introduction

Vijai Kumar Reddy Tangadanchu is an accomplished inventor based in St. Louis, MO. He has made significant contributions to the field of biochemistry, particularly in the development of SphK inhibitors. His work is recognized for its potential applications in various therapeutic areas.

Latest Patents

One of his notable patents is titled "SphK inhibitors and methods of making and using same." This patent focuses on the provision of SphK inhibitors, specifically highlighting an SphK2 inhibiting agent. The agent is characterized as a 1,2,3-triazole that exhibits SphK2 inhibiting activity and selectivity. This innovation opens new avenues for research and treatment options.

Career Highlights

Vijai Kumar Reddy Tangadanchu is affiliated with Washington University, where he continues to advance his research. His dedication to innovation in the field of biochemistry has led to the development of impactful solutions that address critical health challenges.

Collaborations

He has collaborated with esteemed colleagues, including Zhude Tu and Hao Jiang, to further enhance the scope and impact of his research. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise.

Conclusion

Vijai Kumar Reddy Tangadanchu exemplifies the spirit of innovation through his work on SphK inhibitors. His contributions to biochemistry not only reflect his expertise but also hold promise for future advancements in therapeutic applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…